The maximum tumor growth rate predicts clinical outcomes of patients with small‐cell lung cancer undergoing first‐line chemotherapy plus immune‐checkpoint inhibitor therapy

The maximum tumor growth rate predicts clinical outcomes of patients with small‐cell lung cancer undergoing first‐line chemotherapy plus immune‐checkpoint inhibitor therapy

Abstract Background Currently, no biomarkers can accurately predict survival outcomes in patients with SCLC undergoing treatment. Tumor growth rate (TGR; percent size change per month [%/m]) is suggested as an imaging predictor of response to anti‐cancer treatment. We aimed to evaluate the predictiv...

Full description

Bibliographic Details
Main Authors: Xiang Chen, Xueyuan Chen, Tingting Liu, Ting Zhou, Gang Chen, Huaqiang Zhou, Yan Huang, Wenfeng Fang, Yunpeng Yang, Ningning Zhou, Likun Chen, Silang Mo, Li Zhang, Yuanyuan Zhao
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
chemoimmunotherapy
first‐line treatment
SCLC
small cell lung cancer
survival
tumor growth rate
Online Access:https://doi.org/10.1002/cam4.5611

Internet

https://doi.org/10.1002/cam4.5611

Similar Items